You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The method may improve the performance of circulating tumor DNA-based detection assays for routine screening and cancer relapse testing.
The researchers, who also performed whole-genome sequencing on 853 macaques, found new lineage-specific genes and expanded gene families in the monkeys.
Some are comparing iGenomics, a former high school intern's creation, to the fictional "medical tricorder" of "Star Trek" fame.
By chopping RNA-seq reads into smaller bits, UW-Tacoma data scientists are able to cut the alignment step to one minute, but the approach has skeptics.
Ceres plans to develop its Nanotrap technology to isolate undetectable levels of circulating tumor DNA in blood samples from non-small cell lung cancer patients.
The company believes its tests can already help oncologists better assess post-surgery risk, though prospective validation would be necessary for broad claims.
The 20-minute PCR-based test had near complete agreement with lab-based testing.
Called diaPASEF, the method uses the ion trapping function of the timsTOF instrument to enable more efficient sampling of peptide precursor ions.
The spatial molecular imager will be NanoString's next play in a growing market that it says is worth more than $12 billion, including diagnostic applications.
Called direct infusion–shotgun proteome analysis, the approach uses ion mobility in place of liquid chromatography to enable higher-throughput experiments.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.